<DOC>
	<DOC>NCT00706017</DOC>
	<brief_summary>This observational study is conducted in North America. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir速 under normal clinical practice conditions.</brief_summary>
	<brief_title>Observational Study to Evaluate the Safety of Levemir速 in Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 1 or 2 diabetes Including newly diagnosed not on insulin or insulin analogue treatment Selection at the discretion of the physician Adult patients with type 1 and 2 diabetes mellitus, and type 1 patients 6 years and older Current treatment with Levemir速 Previously enrolled in the study Hypersensitivity to Levemir速</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>